title: The tryptophan switch: changing ligand-binding specificity from type I to type II in SH3 domains.
abstract: The ability of certain Src homology 3 (SH3) domains to bind specifically both type I and type II polyproline ligands is perhaps the best characterized, but also the worst understood, example in the family of protein-interaction modules. A detailed analysis of the structural variations in SH3 domains, with respect to ligand-binding specificity, together with mutagenesis of SH3 Fyn tyrosine kinase, reveal the structural basis for types I and II binding specificity by SH3 domains. The conserved Trp in the SH3 binding pocket can adopt two different orientations that, in turn, determine the type of ligand (I or II) able to bind to the domain. The only exceptions are ligands with Leu at positions P(-1) and P(2), that deviate from standard poly-Pro angles. The motion of the conserved Trp depends on the presence of certain residues located in a key position (132 for Fyn), near the binding pocket. SH3 domains placing aromatic residues in this key position are promiscuous. By contrast, those presenting beta-branched or long aliphatic residues block the conserved Trp in one of the two possible orientations, preventing binding in a type I orientation. This is experimentally demonstrated by a single mutation in Fyn SH3 (Y132I) that abolishes type I ligand binding, while preserving binding to type II ligands. Thus, simple conformational changes, governed by simple rules, can have profound effects on protein-protein interactions, highlighting the importance of structural details to predict protein-protein interactions.
authors.affiliation: Instituto de Biología Molecular y Celular, Universidad Miguel Hernández, Edif. Torregaitán, Avda. del Ferrocarril s/n, 03202 Elche Alicante, Spain.
authors.forename: Gregorio
authors.initials: G
authors.lastname: Fernandez-Ballester
authors.forename: Clara
authors.initials: C
authors.lastname: Blanes-Mira
authors.forename: Luis
authors.initials: L
authors.lastname: Serrano
mesh_terms: D000595:Amino Acid Sequence; D004926:Escherichia coli / Q000201:enzymology; D006801:Humans; D007930:Leucine / Q000737:chemistry / Q000378:metabolism; D008024:Ligands; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D010455:Peptides / Q000737:chemistry / Q000378:metabolism; D011485:Protein Binding; D011487:Protein Conformation; D011505:Protein-Tyrosine Kinases / Q000737:chemistry / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D051076:Proto-Oncogene Proteins c-fyn; D017386:Sequence Homology, Amino Acid; D014364:Tryptophan / Q000737:chemistry* / Q000378:metabolism; D018909:src Homology Domains / Q000502:physiology*
chemical_list: D008024:Ligands; D010455:Peptides; D011518:Proto-Oncogene Proteins; C011083:polyproline; D014364:Tryptophan; D011505:Protein-Tyrosine Kinases; C494957:FYN protein, human; D051076:Proto-Oncogene Proteins c-fyn; D007930:Leucine